An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems

The need for the safety monitoring of the COVID-19 vaccine is unprecedented. It is an ongoing process starting from different phases of clinical trials and continued to post-marketing to tackle the emergency used authorized COVID-19 vaccines across the world. Rapid detection, exchange, prioritizati...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Manal Mohammed Younus, Ali Azeez Al-Jumaili
Formato:	article
Lenguaje:	EN
Publicado:	University of Minnesota Libraries Publishing 2021
Materias:	Pharmacy and materia medica RS1-441
Acceso en línea:	https://doaj.org/article/cb09242c67014f9dbb7ccbead27eb253
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cb09242c67014f9dbb7ccbead27eb253
record_format	dspace
spelling	oai:doaj.org-article:cb09242c67014f9dbb7ccbead27eb2532021-12-05T18:44:06ZAn Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems10.24926/iip.v12i4.42942155-0417https://doaj.org/article/cb09242c67014f9dbb7ccbead27eb2532021-10-01T00:00:00Zhttps://pubs.lib.umn.edu/index.php/innovations/article/view/4294https://doaj.org/toc/2155-0417 The need for the safety monitoring of the COVID-19 vaccine is unprecedented. It is an ongoing process starting from different phases of clinical trials and continued to post-marketing to tackle the emergency used authorized COVID-19 vaccines across the world. Rapid detection, exchange, prioritization, and assessment of safety signals based on available real-world data, surveillance of Adverse events following immunization (AEFI), and adverse event of special interest (AESI) by studying the observed/expected cases. Enhanced collaboration, and availability of resources, tools, and methods will add to the lessons learned from previous experiences. Manal Mohammed YounusAli Azeez Al-JumailiUniversity of Minnesota Libraries PublishingarticlePharmacy and materia medicaRS1-441ENINNOVATIONS in Pharmacy, Vol 12, Iss 4 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Pharmacy and materia medica RS1-441
spellingShingle	Pharmacy and materia medica RS1-441 Manal Mohammed Younus Ali Azeez Al-Jumaili An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems
description	The need for the safety monitoring of the COVID-19 vaccine is unprecedented. It is an ongoing process starting from different phases of clinical trials and continued to post-marketing to tackle the emergency used authorized COVID-19 vaccines across the world. Rapid detection, exchange, prioritization, and assessment of safety signals based on available real-world data, surveillance of Adverse events following immunization (AEFI), and adverse event of special interest (AESI) by studying the observed/expected cases. Enhanced collaboration, and availability of resources, tools, and methods will add to the lessons learned from previous experiences.
format	article
author	Manal Mohammed Younus Ali Azeez Al-Jumaili
author_facet	Manal Mohammed Younus Ali Azeez Al-Jumaili
author_sort	Manal Mohammed Younus
title	An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems
title_short	An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems
title_full	An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems
title_fullStr	An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems
title_full_unstemmed	An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems
title_sort	overview of covid-19 vaccine safety and post-marketing surveillance systems
publisher	University of Minnesota Libraries Publishing
publishDate	2021
url	https://doaj.org/article/cb09242c67014f9dbb7ccbead27eb253
work_keys_str_mv	AT manalmohammedyounus anoverviewofcovid19vaccinesafetyandpostmarketingsurveillancesystems AT aliazeezaljumaili anoverviewofcovid19vaccinesafetyandpostmarketingsurveillancesystems AT manalmohammedyounus overviewofcovid19vaccinesafetyandpostmarketingsurveillancesystems AT aliazeezaljumaili overviewofcovid19vaccinesafetyandpostmarketingsurveillancesystems
_version_	1718371090892324864

An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems

Ejemplares similares